English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pumarix (pandemic influenza vaccine (H5N1) (split...) – Packaging - J07BB02

Updated on site: 09-Oct-2017

Medication namePumarix
ATC CodeJ07BB02
Substancepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
ManufacturerGlaxoSmithKline Biologicals S.A.  

Article Contents

EU Number

Invented name

Strength

Pharmaceutical

Route of

Packaging

Content

 

 

--1

Form

Administration

 

 

 

 

(concentration)

EU/1/10/664/001

Pumarix

Suspension and

Intramuscular use

suspension

suspension: 2.5 ml;

 

 

 

emulsion for

 

 

(H5N1): vial

emulsion: 2.5 ml

 

 

 

emulsion for

 

 

(glass);

 

 

 

 

 

injection

 

 

em

lsion

 

 

 

 

 

 

 

(

dj

v

nt):

 

 

 

 

 

 

 

vi

l (gl

ss)

 

 

 

 

 

 

longer

authorised

_ _1

 

 

 

 

 

 

 

 

3.75 µg HA

 

 

 

 

 

 

 

 

After mixing, 1 dose (0.5 ml) contains:

 

 

 

 

 

 

 

Split influenza virus inactivated, containing antigen* equivalent to:

no

 

 

 

 

A/Indonesia/05/2005 (H5N1) 3.75 micrograms**

 

 

 

 

 

 

 

* propagated in eggs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

** haemagglutinin

 

 

 

 

 

 

 

 

 

 

AS03 adjuvant composed of squalene (10.69 milligrams), DL-α-t copherol (11.86 milligrams) and polysorbate 80 (4.86 milligrams)

 

Medicinal

product

 

 

 

 

 

 

 

 

 

1/1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Comments

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Help
  • Get it on Google Play
  • About
  • Info on site by:

  • Presented by RXed.eu

  • 27558

    prescription drugs listed